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ABSTRACT 
Mycobacterium tuberculosis (Mtb) is known to 
modulate the host immune responses to facilitate its 
persistence inside the host cells. One of the key 
mechanisms includes repression of class-II 
transactivator (CIITA) and MHC-II expression in 
infected macrophages. However, the precise 
mechanism of CIITA and MHC-II down-regulation 
is not well studied. Mtb 6-kDa early secretory 
antigenic target (ESAT-6) is a known potent 
virulence and antigenic determinant.  Mtb genome 
encodes 23 such ESAT-6 family proteins. We 
herein report that Mtb and M. bovis-BCG infection 
down-regulated the expression of CIITA/MHC-II 
by inducing hypermethylation in histone H3 Lysine 
9 (H3K9me2/3). Further, we show that Mtb ESAT-
6 family protein EsxL, encoded by Rv1198, is 
responsible for the down-regulation of 
CIITA/MHC-II by inducing H3K9me2/3. We 
further report that Mtb esxL induced the expression 
of nitric oxide synthetase (iNOS), NO production 
and p38-MAPK pathway, which in turn was 
responsible for the increased H3K9me2/3 in CIITA 
via up-regulation of euchromatic histone-lysine N-
methyltransferase 2 (G9a). In contrast, inhibition of 
iNOS, p38-MAPK and G9a abrogated H3K9me2/3 
resulting in increased CIITA expression. 
Chromatin immune precipitation assay confirmed 
that hypermethylation at the promoter IV (pIV) 
region of CIITA is mainly responsible for the 
CIITA down regulation and subsequently antigen 
presentation. We found that co-culture of 
macrophages infected with esxL expressing M. 
smegmatis and mouse spleenocytes led to down-
regulation of IL-2, a key cytokine involved in T-cell 
proliferation. In summary, we show that Mtb esxL 
inhibits antigen presentation by enhancing 
H3K9me2/3 on CIITA promoter thereby repressing 
its expression through NO and p38-MAPK 
activation. 
 
INTRODUCTION 
Pathogenic bacteria employ various host immune 
evasion strategies to facilitate its survival in the host 
cells. One of such mechanisms involves induction 
of epigenetic modifications in the host DNA, 
histone proteins and RNA by bacterial proteins (1, 
2). Various bacterial virulent proteins have been 
shown to promote host chromatin and/or histone 
modifications via different signaling cascades. For 
example, Shigella flexneri, Listeria monocytogenes 
and Helicobacter pylori regulate p38 mitogen-
activated protein kinase (MAPK) pathway by 
promoting histone 3(H3) phosphorylation and 
acetylation processes that subsequently modulate 
the secretion of various cytokines and chemokines 
in infected cells (3-5). S. flexneri infection inhibited 
MAPK dependent histone H3 serine 10 (H3S10) 
phosphorylation that impaired the recruitment of 
nuclear factor-kappa B (NF-B) at the interleukin-
8 (IL-8) promoter (4). On the other hand L. 
monocytogenes promoted H3K8 acetylation 
resulting in transcriptional activation of IL-8 via 
MAPK pathway (6, 7). Similarly H. pylori 
promoted NF-κB binding to the IL-6 promoter by 
inducing H3S10 phosphorylation via ERK and p38 
(8, 5). 
Tuberculosis (TB), caused by an 
intracellular pathogen Mtb, is a life threatening 
disease that infects 9 million people and kills more 
than 1.5 million people every year worldwide (9). 
According to the World Health Organization report, 
one-third of the global population is latently 
infected with Mtb but only 5 to 10 % of people with 
latent TB develop into an active TB disease (10).  
The underlying mechanisms responsible for this 
adaptation are poorly understood. Although, 
several reports are available on the correlation of 
other bacterial infections and epigenetics in the 
disease outcome, very little is known about the 
dynamics of epigenetic changes during 
mycobacterial infection. Macrophages, the primary 
host cells of Mtb, play a crucial role in recognition, 
phagocytosis and killing of mycobacteria. Non-
pathogenic mycobacteria such as M. smegmatis 
(Msm) are readily killed by macrophages, whereas 
pathogenic mycobacteria (Mtb) are able to survive 
for extended period of time by manipulating the 
macrophage immune functions (11). These include 
prevention of phagolysosome fusion, inhibition of 
phagosome acidification due to depletion of 
vesicular proton-ATPase (V-ATPase), evasion 
from toxic effects of nitric oxide (NO) and reactive 
oxygen species (ROS), suppression of protective 
cytokine synthesis and T-helper (Th)-1 responses, 
and inhibition of apoptosis (12-15).   
Recently, few reports have demonstrated 
that Mtb infection induces epigenetic modifications 
in host cells to aid its replication, propagation and 
protection from host immune responses (16,17,18). 
Mycobacterial cell wall protein, LpqH, was shown 
to block interferon-gamma (IFN-γ) induced 
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transcription of class-II transactivator (CIITA) by 
SWI/SNF binding and histone deacetylation at the 
CIITA promoter (19). IFN-γ induces the expression 
of major histocompatibility complex class II (MHC 
class II) by activating the transcription of CIITA 
(20). Another study has shown that Mtb 
downregulates HLA-DR transcription and MHC-II 
by inhibiting IFN-γ dependent histone acetylation 
and by recruiting mSin3A repressor at the HLA-DR 
promoter (21).  
Inducible nitric oxide synthase (iNOS) 
catalyzes the formation of nitric oxide (NO), which 
helps in bacterial clearance, including Mtb (22, 23). 
It has been shown that NO knock-out mice were 
more susceptible to Mtb infection (24). In addition 
to its antibacterial properties, NO also mediate 
nitration, nitrosation and nitrosylation of key 
signalling molecules that determine the fate of 
macrophages and dendritic cells during bacterial 
infection (25-29). NO was shown to induce CIITA 
and MHC-II inhibition by signalling cross talks 
between NOTCH-PKCδ-MAPK-NFkβ-KLF4 
pathway during M. bovis BCG infection (30).  
Mtb early secretory antigenic target 
protein-6 (ESAT-6; esxA) is a known virulent as 
well as T-cell antigenic determinant (31). Mtb 
ESAT-6 was involved in the cytosolic escape of 
bacteria by inducing pore formation in the 
phagosomal membrane (32, 33). Previously, 
ESAT-6 protein was also reported to decrease 
histone H4 acetylation and H3K4 methylation at 
CIITA promoter (pI) (16). There are at least 23 such 
ESAT-6 family proteins present in the Mtb genome. 
However, the functions of many of them are still 
unknown. Herein, we showed that Mtb esxL, a 
previously uncharacterized member of ESAT-6 like 
family protein encoded by Rv1198, suppresses 
antimycobacterial defence mechanisms of 
macrophages by inhibiting the expression of CIITA 
and subsequently MHC-II molecules. Further 
mechanistic studies revealed that CIITA and MHC-
II down-regulation by esxL was due to induction of 
H3K9 hypermethylation in the CIITA-IV promoter 
region (pIV), as determined by Western blotting 
and chromatin immuno-precipitation (ChIP) 
assays. We further showed that recombinant M. 
smegmatis expressing esxL (Msm esxL) induced the 
synthesis of p38 MAPK, iNOS and NO that 
promoted H3K9me2/3 at the CIITA promoter via 
up-regulation of G9a (also known as euchromatic 
histone-lysine N-methyltransferase2 , EHMT2), 
whereas Mtb ∆esxL mutant  down-regulated 
H3K9me2/3. EsxL mediated H3K9me2/3 also 
resulted in inhibition of antigen presentation and 
secretion of interleukin-2 (IL-2), a key cytokine 
involved in T-cell activation. In summary, we 
identified another mechanism by which Mtb aids its 
persistence by repressing CIITA/MHC-II via G9a, 
p38 and NO dependent H3K9me2/3 in promoter IV 
of CIITA.  
 
RESULTS 
M. smegmatis esxL showed prolonged 
intracellular survival in RAW 264.7 and THP-1 
cells 
Mtb ESAT-6 is known as a potent virulence as well 
as antigenic determinant (31, 34). Recently, we 
have shown that Mtb Rv2346c, a member of ESAT-
6 like family proteins, endow bacterial persistence 
by dampening the antibacterial effector functions 
by inducing genomic instability and autophagy in 
macrophages (35). Using Msm as a surrogate 
model, we (35, 36, 37) and several other groups (38, 
39) have proved the functions of several Mtb 
proteins in pathogenesis. Similarly, in this study we 
ectopically expressed one of the Mtb ESAT-6 
family proteins EsxL, encoded by Rv1198, in Msm 
(Msm esxL) and also constructed Mtb esxL deletion 
mutant (Mtb ∆esxL) and studied its role in 
pathogenesis. Figure 1A shows genetic 
organization of esxL in the Mtb genome. It is 
located downstream of another ESAT-6 like protein 
esxK, encoded by Rv1197. esxL has previously 
been identified from the membrane fraction (40) 
and culture filtrates (41) of Mtb with unknown 
function. It was reported that immunization of 
BALB/c mice with Rv1198 induced a pro-
inflammatory response with elevated levels of 
tumor necrosis factor-alpha (TNF-α) and IL-6, 
along with low induction of IFN-γ, IL-2 and IL-10 
(42). EsxL has been assigned to a member of 
Rv1793, Rv1037c and Rv2346c, all belonging to 
the ESAT-6 family proteins (43). Despite of these 
important characteristics shown by esxL, its role in 
pathogenesis is still unknown.  Comparative 
genome analyses revealed that M. bovis-BCG 
genome contain Mb1230, an orthologue of Mtb 
esxL; while Msm genome does not contain any 
esxL orthologue (Tuberculist database). 
 
As esxL was found to be a member of 
ESAT-6 family protein that is known as a key 
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virulence factor, we compared the intracellular 
bacillary persistence of Msm harboring pSMT3 
vector (Msm pSMT3) and Msm expressing esxL 
(Msm esxL) strains in mouse macrophage RAW 
264.7 and PMA differentiated THP-1 cells. The 
infected cells were lysed at different time points 
post-infection and the bacterial survival was 
determined by colony forming unit (CFU) 
enumeration. The bacterial input and time zero (T0) 
counts were determined to calculate the 
intracellular bacterial survival. The recombinant 
Msm esxL showed significantly high bacterial 
burden in RAW 264.7 (P < 0.001; Figure 1B) and 
THP-1 cells (P < 0.001; Figure 1C) when compared 
with Msm pSMT3 strain after 24 h of infection. We 
did not observe any differences in the growth 
patterns of Msm wild-type (Msm WT), Msm 
pSMT3 and Msm esxL strains (Figure 1D) 
suggesting that the observed increased bacterial 
survival was not due to differences in the growth 
kinetics of bacteria. The intracellular and 
extracellular expressions of esxL were determined 
by qRT-PCR at 4, 12 and 24 h time points. As 
shown, esxL was expressed under both in-vitro 
(Figure 1E) and ex-vivo (Figure 1F) conditions. In 
conclusion, above data showed that Mtb esxL has a 
role in increased bacterial persistence inside the 
macrophages.  
 
EsxL induced NO production and iNOS 
expression in macrophages 
iNOS, which catalyzes the formation of NO, 
perform immunomodulatory activities that 
determine the outcome of Mtb infection (45). In 
addition to its antibacterial properties, NO is also 
known as a key regulator in initiation and 
maintenance of anti-TB protective immunity (46) 
and to modulate the cellular signaling pathways that 
can either support or inhibit the bacterial growth 
depending up on the cytokine milieu (47). 
Previously, ESAT-6 was shown to induce NO 
production in macrophages (48). We found 
significantly higher NO production in Msm esxL 
infected RAW 264.7 cells as compared to Msm 
pSMT3 infected cells at the indicated time points (P 
< 0.05 and P< 0.01; Figure 2A). Similarly, we 
observed approximately 18-fold increase in iNOS at 
transcriptional (P< 0.001; Figure 2B) and 
translational levels (Figure 2C) in Msm esxL 
infected macrophages. Immunofluorescence 
studies using iNOS specific antibody also showed 
significantly increased expression in Msm esxL 
infected macrophages as compared to uninfected 
and Msm pSMT3 infected cells (Figure 2D). On the 
contrary, decreased iNOS expression was observed 
in Mtb esxL infected THP-1 cells when compared 
with Mtb infected cells (Figure 2E). The generation 
of Mtb esxL is shown in Fig 1G and H. We did not 
observe any significant differences in the 
production of reactive oxygen species (ROS) in 
infected macrophages (data not shown) indicating 
that Mtb esxL specifically induces NO production 
in macrophages. 
 
EsxL down-regulated MHC-II and CIITA in 
macrophages  
Pathogenic mycobacteria are known to down-
regulate the surface expression of MHC-II 
molecules in macrophages (49). The MHC-II 
dependent antigen presentation is tightly regulated 
by a key transcription factor class II transactivator 
(CIITA). Mice deficient for CIITA showed a 
marked reduction in MHC-II expression (50). It has 
been shown that M. bovis-BCG infection inhibited 
MHC-II expression by inducing the NO production 
in macrophages (30). In view of these reports, we 
checked the expression of MHC-II and CIITA in 
Mtb, Mtb esxL, Msm pSMT3 and Msm esxL 
infected macrophages. As shown, Msm esxL 
infection abrogated CIITA expression at both 
transcriptional (P< 0.01; Figure 3A) and 
translational levels (Figure 3B). Mtb infected THP-
1 cells also showed time-dependent decrease in 
CIITA expression (Figure 3C), whereas increased 
CIITA expression was observed in Mtb esxL 
infected cells (Figure 3D). We further confirmed 
the effect of CIITA on MHC-II expression. A 
significant decrease in MHC-II expression was 
observed at both transcriptional (P< 0.01; Figure 
3E) and translational (Figure 3F) levels in Msm 
esxL infected RAW264.7 macrophages when 
compared with Msm pSMT3 infected cells. Flow 
cytometry analysis also showed a significant 
decrease in MHC-II expression in Msm esxL 
infected THP-1 (Figure 3G) and RAW264.7 
macrophages (Figure 3H). In agreement with 
previous reports, we also observed time dependent 
decrease in MHC-II expression in Mtb infected 
THP-1 cells (Figure 3I) when compared with Mtb 
esxL infected cells (Figure 3J). Altogether, these 
data suggest that Msm esxL, M. bovis-BCG and Mtb 
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mediated MHC-II inhibition is due to down-
regulation of CIITA levels.  
 
M. smegmatis esxL infection down-regulated IL-2 
and IL-10 and up-regulated IL-6 and TNF-α 
production in macrophages 
It is known that inhibition of antigen presentation 
prevents T-cell activation (51). As mentioned 
above, IL-2 is a key cytokine involved in T-cell 
activation (52, 53). Therefore, we checked IL-2 
levels using Bioplex cytokine analysis kit. For this 
macrophages were first infected with Msm pSMT3 
and Msm esxL strains followed by co-culture with 
BALB/c mice spleenocytes. We found significant 
down-regulation of IL-2 (P<0.05, Figure 4A) and 
IL-10 (P<0.05, Figure 4B) cytokines in supernants 
obtained from Msm esxL infected cells as compared 
to Msm pSMT3 infection after 24 h. However, 
treatment with G9a inhibitor UNC0638 increased 
the production of both cytokines suggesting that 
Msm esxL infection suppressed T-cell activation. In 
contrast, TNF-α (P<0.01, Figure 4C) and IL-6 
(P<0.01, Figure 4D) were up-regulated in Msm 
esxL infected cells.   
 
M. smegmatis esxL induce histone modification 
(H3K9 hypermethylation) in macrophages  
Few studies have shown that pathogenic 
mycobacteria and its antigens induce epigenetic 
changes to evade host immune responses (16, 19, 
53 ). We hypothesized that esxL might render 
repressive epigenetic modifications at the CIITA 
promoter that subsequently inhibit MHC-II 
dependent antigen presentation. H3K9me2/3 is 
involved in transcriptional repression (54). 
Therefore, we analyzed the status of H3K9me2/3 in 
infected macrophages. Indeed, immuno-blotting 
(Figure 5A) and immuno-fluorescence (Figure 5B) 
analysis showed significantly elevated levels of 
H3K9me2/3 in Msm esxL infected macrophages as 
compared to control cells. A significant increase in 
H3K9me2/3 puncta was observed in Msm esxL 
infected cells. We did not observe any significant 
differences in H3K4me3 and total H3 in Msm 
pSMT3 and Msm esxL infected macrophages 
(Figure 5C) indicating that esxL induce 
H3K9me2/3 in macrophages. 
 
M. bovis BCG and M. tuberculosis infection also 
induce H3K9me2/3 in macrophages 
To further confirm the role of esxL in inducing 
repressive histone modification, we analyzed the 
expression of H3K9me2/3 in M. bovis-BCG, Mtb 
and Mtb esxL infected macrophages. 
Concordantly, Western blot analysis showed 
increased levels of H3K9me2/3 in M. bovis BCG 
(Figure 5D) and Mtb (Figure 5E) infected 
macrophages suggesting that Mtb and BCG may 
down-regulate CIITA expression by inducing 
H3K9me2/3 in macrophages. In contrast, decreased 
H3K9me2/3 expression was observed in Mtb ΔesxL 
infected THP-1 cells when compared with Mtb 
infected cells (Figure 5F). 
 
M. smegmatis esxL and M. bovis-BCG induce 
H3K9me2/3 modification by up-regulating 
EHMT2 methyltransferase activity 
To further investigate the mechanism of 
H3K9me2/3 induction, we studied the activity of 
methyltransferases in infected macrophages.  
Several H3K9-specific lysine methyltransferases 
such as Eset, KMT1E, G9a are involved in 
H3K9methylation (55). Among them, G9a also 
known as euchromatic histone-lysine N-
methyltransferase 2 (EHMT2), is a dominant 
histone methyl transferase responsible for 
methylation of H3K9 (56). Transcriptional analysis 
showed significant increase in G9a level in Msm 
esxL (P< 0.01; Figure 5G) and Mtb (P<0.001; 
Figure 5H) infected THP-1 cells, whereas Mtb 
esxL infection down-regulated G9a expression 
(P<0.001; Figure 5H). Otherwise, treatment with 
G9a inhibitor (UNC0638) subdued the expression 
of H3K9me2/3 in Msm esxL infected macrophages 
when compared with untreated cells (Figure 5I). 
Similar results were obtained with M. bovis-BCG 
infection. In which, BCG infection increased the 
level of H3K9me2/3, while treatment with G9a 
inhibitor reduced H3K9me2/3 level (Figure 5D). 
Collectively, these results indicate that Msm esxL, 
Mtb and M. bovis-BCG induce H3K9me2/3 via G9a 
methyltranferase.  
To assess whether CIITA down-regulation 
during Msm esxL infection is dependent on G9a 
mediated H3K9me2/3, we checked the expression 
of CIITA in untreated and G9a inhibitor treated 
macrophages. Immunoblot analysis showed that 
pretreatment with G9a inhibitor severely reduced 
the capacity of Msm esxL to inhibit CIITA 
expression in macrophages (Figure 5I) indicating 
that observed CIITA down-regulation was due to 
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G9a dependent induction of H3K9me3 in infected 
macrophages.  
 
ChIP analysis showed that H3K9 
hypermethylation occurs at promoter IV region of 
CIITA 
ChIP assay was performed to check H3K9me2/3 in 
CIITA promoter. Sequence analysis revealed the 
presence of three promoter regions (CIITApI, 
CIITApIII and CIITApIV) in CIITA. As shown, 
Msm esxL down-regulated CIITA expression by 
inducing H3K9me2/3 at promoter IV region of 
CIITA (P< 0.001; Figure 5J), while no such 
induction was observed in CIITApI and CIITApIII 
promoters (data not shown). Moreover, we did not 
observe any H3K9me2/3 enrichment in Msm 
pSMT3 infected cells. Importantly, inhibition of 
G9a significantly decreased H3K9 
hypermethylation at CIITA promoter IV in Msm 
esxL infected macrophages (P<0.01; Figure 
5K).These results clearly indicate that Msm esxL 
down-regulate G9a dependent CIITA expression by 
promoting H3K9me2/3 in promoter IV region of 
CIITA.  
 
M. smegmatis esxL trigger H3K9me2/3 mediated 
CIITA inhibition by inducing MAPK signaling 
pathway  
NO acts as a key intermediate in regulation of cell-
fate decisions by modulating several signaling 
pathways in the host cells (57, 58). Hence, we 
postulated that signaling cascades that regulate NO 
production could act as a focal point in Msm esxL 
infection-triggered histone modification that 
subsequently leads to inhibition of MHC-II or 
CIITA. Mitogen-activated protein kinase (MAPK) 
pathways are known to regulate eukaryotic gene 
expression by modulating the chromatin structure 
of regulatory elements (59). Increased MAPK leads 
to recruitment of HDACs leading to gene 
repression (60). Mycobacteria, in addition to 
selective antigens, are known to induce MAPK 
signaling in macrophages (61). In this context, we 
addressed the role for MAPK signaling pathway in 
the regulation of H3K9me2/3 and CIITA 
expression. We found that Msm esxL infection 
triggered the activation of p-P38 (Figure 6A) and p-
ERK (Figure 6B) when compared with control 
conditions. Similarly Mtb infection also induced p-
P38 expression when compared with Mtb ΔesxL 
infected THP-1 cells (Figure 6C). Importantly, 
pretreatment with p38 inhibitor (SB203580) 
abrogated the Msm esxL induced inhibition of 
CIITA (upper panel, Figure 6D). Similarly, 
treatment with SB203580 down-regulated the 
expression of H3K9me2/3 in Msm esxL infected 
macrophages (middle panel, Figure 6D). On the 
other hand, inhibition of p-ERK by the 
pharmacological inhibitor U0126 did not show any 
effect on the expression of both CIITA and 
H3K9me2/3 during Msm esxL infection when 
compared with untreated macrophages (Figure 6E). 
These results clearly suggest that Msm esxL 
triggered P38 MAPK signaling pathway hold the 
capacity to modulate H3K9me2/3 expression to 
regulate CIITA/MHC-II expression. 
 
Msm esxL induced NO production regulates 
induction of H3K9me2/3 and inhibition of CIITA 
expression  
Next, we assessed the role of iNOS/NO during Msm 
esxL-infection in modulating the expression of 
H3K9me3 and CIITA. For this, macrophages were 
infected with Msm pSMT3 and Msm esxL strains 
and then treated with an iNOS inhibitor 1400W. 
Treatment with 1400W inhibitor severely down-
regulated the expression of H3K9me2/3 in Msm 
esxL infected macrophages (Figure 6F). On the 
other hand, inhibition of iNOS led to increased 
expression of CIITA when compared with 
untreated conditions (Figure 6F). These results 
confirm the crucial role of NO in repression of 
CIITA by increasing hypermethylation of H3K9. 
 
 
DISCUSSION 
Mtb adopt various strategies to evade host defense 
mechanisms to facilitate its survival in the host 
cells. One such mechanism involves epigenetic 
modifications in the host proteins to dampen 
antibacterial effector functions of host cells. In this 
context, various Mtb proteins including ESAT-6, 
CFP-10, lipoproteins and PE/PPE proteins are 
known to be involved in the establishment of 
infection process (62-70). Herein, we report that 
Mtb esxL repress CIITA/MHC-II expression by 
inducing H3K9me2/3 in CIITA promoter.
 Previously we and several other studies 
have used Msm as a surrogate model to elucidate 
the function of Mtb proteins in pathogenesis. For 
example, expression of Mtb Mce4A protein in a 
non-pathogenic Escherichia coli increased invasion 
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in HeLa cells (71), while expression of Mtb PE 
proteins in Msm increased its virulence properties 
(72). Based on these evidences, we expressed Mtb 
esxL in Msm strain and also deleted esxL from Mtb 
genome (Mtb esxL) and proved its function using 
macrophage infection model.  
Msm genome does not contain esxL 
orthologue, therefore, the observed phenotypes can 
be attributed to the ectopic expression of esxL in 
Msm. Using human and mice macrophage infection 
models we showed that recombinant Msm esxL 
strain survive more as compared to control strains 
indicating that esxL is involved in bacillary 
persistence in macrophages. It is well established 
that pathogenic Mtb facilitate its survival by 
modulating ROS and NO production (73-76). We 
observed that Msm esxL strain increased NO and 
iNOS production in infected macrophages, while 
inhibition of iNOS decreased the intracellular 
survival of Msm esxL. Contrary, Mtb esxL reduced 
iNOS expression. The role of NO as an 
antimicrobial agent has been extensively studied in 
the context of host defense mechanisms. 
Nevertheless, previous study has provided evidence 
that reactive nitrogen intermediate (RNI) help in 
proliferation of Mtb suggesting bacteriostatic effect 
of RNI on Mtb (77). In addition to antimicrobial 
properties, NO/iNOS are also known to modulate 
several signaling cascades that regulate cell fate 
decisions of host cells (56, 58). Previous studies 
have shown that Mtb down-regulates CIITA thus 
altering antigen presentation (78). However, 
specific Mtb protein responsible for observed 
down-regulation was not known. Our study has 
provided several evidences that esxL could be 
responsible for CIITA down-regulation. It has been 
shown that epigenetic modifications are involved in 
regulating CIITA expression (49, 79, 80). Studies 
also showed that Mtb proteins like LpqH and 
ESAT-6 cause CIITA inhibition by decreasing 
histone H3K4 methylation level and acetylation 
levels (16,19). Our study has unambiguously 
shown that Mtb esxL induced H3K9me2/3 in host 
cells. H3K9me1/2/3 is known for transcriptional 
repression of the gene which undergoes 
modification at its promoter region (54, 42). We 
have further provided evidences that esxL induced 
H3K9me2/3 are mediated via G9a, which is a 
known histone methyl transferase responsible for 
H3K9 methylation. Inhibition of G9a down-
regulated H3K9me2/3 and simultaneously resulted 
in up-regulation of CIITA indicating that G9a 
methyl transferase is responsible for H3K9 
hypermethylation in CIITA promoter. Indeed, ChIP 
assay showed that Mtb esxL promoted H3K9me2/3 
at the promoter IV region of CIITA gene, which led 
to the transcriptional repression of CIITA that 
subsequently perturbed antigen presentation and T-
cell activation. Level of H3K9me2/3 was also 
found to be increased in M. bovis-BCG and Mtb 
infected macrophages, whereas levels of 
H3K9me2/3, CIITA, MHC-II, iNOS and P38 was 
down-regulated in Mtb esxL infected 
macrophages. M. bovis-BCG contains esxL 
orthologue, Mb1230. Therefore, M. bovis BCG 
induced H3K9me2/3 could be attributed to this 
protein.  
MAPK signaling pathway plays a crucial 
role in mycobacterial infection. Mtb 38-kDa protein 
was shown to induce TNF-α and IL-6 through 
MAPK pathway to facilitate mycobacterial 
infection (42). As shown before, MAPK 
components ERK and P38 are known to alter gene 
transcription by altering chromatin structure (59). 
The recruitment of HDACs at promoter site of the 
gene is known to be facilitated by MAPK (60). In 
our study, we found that Msm esxL infection 
upregulated ERK and p38 levels in macrophages. 
However, inhibition of p38 downregulated the 
expression of H3K9me2/3 and CIITA indicating 
that esxL induced H3K9me2/3 is mediated via p38 
signaling pathway. Previous studies have shown the 
involvement of p38 in repressive epigenetic 
modification. Mtb LpqH activates p38, which in 
turn facilitates the recruitment of HDAC to the 
promoter of CIITA, thus repressing gene 
transcription (19). We further showed that esxL 
induced H3K9me2/3 is dependent on NO 
production. There are reports suggesting the 
involvement of NO/iNOS in downregulation of 
CIITA. A study has shown that BCG infection 
increased NO production that upregulated the 
expression of KLF4 transcription factor. KLF4 acts 
as a regulatory switch and inhibits CIITA 
expression (30). 
In summary, we have studied a mechanism 
in detail that leads to repression of CIITA/MHC-II 
during Mtb infection. Figure 7 shows schematic 
representation of a mechanism that leads to 
repression in antigen presentation and T-cell 
activation by inducing H3K9me2/3 in promoter IV 
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region of CIITA via NO, p38-MAPK and G9a 
during infection. 
 
EXPERIMENTAL PROCEDURES 
 
Chemicals, reagents and cell culture conditions 
Mycobacterium smegmatis mc2155 was grown in 
Middlebrook’s 7H9 broth medium (Difco) 
containing 0.05% Tween 80, 0.5% glucose and 
0.5% albumin at 37 0C on a shaker at 120 r.p.m. M. 
tuberculosis H37Rv and M. bovis BCG were grown 
in Middlebrook’s 7H9 broth medium (Difco) 
containing 0.05% Tween 80, 0.5% glucose, 0.5% 
albumin and Oleic Albumin Dextrose Catalase 
(OADC) at 37 0C on a shaker at 120 r.p.m. 
Escherichia coli XL-10 Gold (Stratagene) was 
grown in Luria-Bertani (LB) broth supplemented 
with 20 µg/ml tetracycline. pSMT3 vector was a 
kind gift from Dr. Rakesh Sharma (IGIB, Delhi). 
Murine RAW264.7 macrophage cell line was 
cultured in DMEM Dulbecco’s modified Eagle’s 
medium (DMEM; HiMedia, Mumbai, India) 
supplemented with 10% fetal bovine serum, 1% 
penicillin-streptomycin solution, and 1% L-
glutamine. THP-1 cells (70) were grown in RPMI 
1640 (Gibco) supplemented with 10% FBS, 10 mM 
HEPES, 1 mM sodium pyruvate and penicillin-
streptomycin solution. The cells were seeded onto 
24-well culture dishes at a density of 2x105 cells/ml 
and treated overnight with 20 nM phorbol myristate 
acetate (PMA) (Sigma) for 24 h. Cells were then 
washed three times with PBS and incubated for one 
more day before performing the experiment. Anti- 
iNOS, anti- H3K9me3, anti- phospho –p38, anti- 
phospho- ERK1/2, anti- histone H3, anti- β-actin, 
anti-GAPDH and secondary goat anti- rabbit and 
goat anti-mouse antibodies were purchased from 
Cell Signaling Technologies (USA). Anti- CIITA 
antibody was purchased from Abcam (UK). Anti- 
MHC-II and anti-mouse IgG were procured from 
Santa-cruz (USA). FITC-labelled anti-human 
MHCII antibody was purchased from Invitrogen 
(USA). Goat anti-mouse IgG, Alexa Fluor 633, goat 
anti-rabbit IgG, Alexa Fluor 488 secondary 
antibodies were purchased from Thermofisher 
Scientific (USA). Mounting solution with DAPI 
was purchased from DAKO (USA). All the 
pharmacological inhibitors were purchased from 
Sigma (USA) and Calbiochem (USA) and 
reconstituted in DMSO (Himedia, India) or sterile 
H2O at the following concentrations: 1400W (100 
µM), U0126 (10 µM), SB203580 (10 µM), and 
UNC0638 hydrate (5µM).  
 
Cloning and expression of esxL 
 Mycobacterium tuberculosis esxL was PCR 
amplified using gene specific primers (Table 1) and 
Mtb genomic DNA as template. The PCR amplified 
products were gel purified, sequentially digested 
with PstI and HindIII and cloned into pSMT3 
shuttle vector. The recombinant constructs were 
transformed into competent E. coli XL-10 gold. 
The positive clones were selected on LB agar plates 
supplemented with 20µg/ml tetracycline and 50 
µg/ml hygromycin. The positive clones were 
confirmed by colony PCR and sequencing using 
gene specific primers. Finally the recombinant 
constructs were transformed into electrocompetent 
M. smegmatis. The positive colonies were selected 
on 7H9 medium containing 50 µg/ml hygromycin 
B. The positive transformants were confirmed by 
colony PCR and sequencing using gene specific 
primers. 
 
Generation of M. tuberculosis esxL mutant 
Temperature sensitive phage based transduction 
methodology was used for the generation of Mtb 
esxL deletion mutant (Figure 1G and H). Upstream 
(814 bp) and downstream (812 bp) flank regions 
were PCR amplified and the amplicons were 
digested with PflMI restriction enzyme. Flanks 
were ligated with the compatible sacB+hygr and 
oriE+λcos fragments from pYUB1471to generate 
Allelic Exchange Substrate (AES). AES was 
packaged into phAE159 phasmid (A kind gift from 
Dr. William Jacob’s Lab) and high titer phages 
were generated and transduced into M. tuberculosis 
H37Rv harboring pNit-ET plasmid as describe 
earlier (44).  
 
Intracellular bacterial survival assay 
M. smegmatis wild-type (Msm WT), Msm harboring 
plasmid pSMT3 (Msm pSMT3) and recombinant 
Msm expressing Mtb esxL (Msm esxL) strains were 
grown to mid-exponential phase. Then bacterial 
cultures were pelleted, washed in 1X PBS and re-
suspended in DMEM medium to a final OD600 0.1. 
Bacterial clumps were broken by ultrasonication for 
5 min followed by a low speed centrifugation for 2 
min. RAW264.7 macrophages (2x105 cells/well) 
were seeded on 24-well tissue culture plates with 
media containing no antibiotic solution and grown 
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for 18-20 h.  Cells were infected with Msm WT, 
pSMT3 and Msm esxL strains at an MOI 10 and 
intracellular survival was determined by lysing the 
infected macrophages at different time points and 
bacterial survival was determined by plating the 
serially diluted samples onto 7H9 plates after lysing 
the cells with 0.5% Triton-X 100. The equal input 
and time zero (T0) counts of infecting bacilli were 
determined to calculate the percentage survival. % 
survival= CFU at required time / CFU of bacteria 
added X 100. For THP-1 infection assay, cells were 
first treated with 20 nM phorbol myristate acetate 
(PMA) (Sigma) in RPMI medium and the infection 
assay was performed as described above.  
 
Intracellular expression of esxL 
RAW 264.7 macrophages were infected with Msm 
esxL, RNA was isolated at 4, 12 and 24 h time 
points followed by cDNA synthesis. qRT-PCR was 
performed using the cDNA as templates using gene 
specific primers (Table 1). SigA was used as an 
internal control. 
 
Extracellular expression of esxL 
Msm esxL strain was grown in-vitro for 24 h in 7H9 
broth constituted with 0.05% Tween80 under 
shaking condition. Cell pellets were harvested 
followed by RNA isolation and cDNA synthesis. 
qRT-PCR was performed using gene specific 
primers and cDNA as template. SigA was used as 
an internal control. 
 
Infection with M. tuberculosis H37Rv and Mtb 
ΔesxL 
THP1 cells were maintained in RPMI 1640 
supplemented with 10% heat inactivated FBS and 
differentiated using PMA.  The infection 
experiment with Mtb H37Rv or Mtb ΔesxL strains 
was performed as described earlier (82). For the 
lysate preparation, 8×106 cells were seeded in 10 
cm cell culture dishes and the infection was 
performed at 1:5 multiplicity of infection (MOI). At 
different time points cells were washed with PBS 
and lysed by using 600 l of RIPA buffer, vortexed 
for 30 second and kept in ice. The procedure was 
repeated thrice and the cell lysates were clarified at 
13000 rpm at 40C. 
 
Free Nitric Oxide (NO) estimation 
 RAW264.7 (2x105cells/well) was seeded on 24-
well plates. Next day, the cells were infected with 
Msm WT, pSMT3 and Msm esxL strains for 24 h. 
The accumulation of nitrite was measured by 
mixing 100 µl of culture supernatants with an equal 
volume of Griess reagent (1% sulfanilamide– 0.1% 
naphthylethylenediamine dihydrochloride in 5% 
concentrated H3PO4) in 96-well plates. The plates 
were incubated for 10 min at room temperature and 
absorbance was measured at 550 nm in a microtiter 
plate reader (EPOCH, BioTek, USA). The nitrite 
concentrations (in micromoles per sample) were 
determined by a least-square linear regression 
analysis using sodium nitrite as a standard (5 to 100 
µM range). The values were averaged from three 
independent experiments. 
 
RNA isolation and Quantitative Real-time RT-
PCR 
Total RNA was isolated from infected or uninfected 
macrophages using TRIzol reagent (Invitrogen) as 
per the manufacturer’s protocol. The cDNA 
synthesis kit (Thermofisher Scientific) was used for 
reverse transcription according to the 
manufacturer’s protocol. Quantitative real time RT-
PCR amplification using the SYBR Green PCR 
mixture (KAPA Biosystems) was performed for 
quantification of target gene expression in Real 
Plex master cycler (Eppendorf, Germany) with 
initial denaturation at 95 oC for 10 min, final 
denaturation at 95 oC for 30 s, annealing at 52 oC 
for 30 s and extension at 72 0C for 30 s to generate 
200 bp amplicons. All reactions were repeated at 
least twice independently to ensure reproducibility 
of the result. The mRNA levels were normalized to 
the transcript levels of GAPDH and the relative fold 
changes were calculated. 
 
Western blot analysis 
RAW264.7 cells were infected with Msm WT, 
pSMT3 and Msm esxL. After 24 h of infection, 
protein samples were prepared by cell lysis using 
RIPA buffer (HiMedia) containing 5mM EDTA, 
5mM EGTA, 1 mM PMSF, protease inhibitor 
cocktail, 50mM NaF, 1mM DTT, 1mM Sodium 
orthovanadate. Proteins were electrophoresed in 
12% SDS-PAGE and transferred to polyvinylidene 
difluoride membrane (PVDF) (GE Healthcare Life 
sciences) overnight at 28 Volts. Then the blots were 
blocked with 5% BSA or skimmed milk in TBST 
(20 mM Tris-HCl, pH 7.4, 137 mM NaCl, and 0.1% 
Tween 20) for 60 min. Then blots were incubated 
with primary rabbit IgG antibodies (1:1000) 
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overnight at 4 oC and then with HRP-conjugated 
anti-rabbit or anti-mouse IgG secondary antibodies 
in 5% BSA or skimmed milk (1:1000) for 2 h. The 
membrane was washed using 1X TBST and X-ray 
film was developed using standard 
chemiluminescent solvent. β-actin and GAPDH 
were used as loading controls. 
 
Immunofluorescence 
For immunofluorescence studies, RAW 264.7 
macrophages (5X104) were seeded on coverslips. 
After infecting the cells with Msm pSMT3 and Msm 
esxL, cells were fixed with acetone: methanol (1:1) 
for 20 min at -200C and then blocked with 5% BSA 
for 1h at room temperature and stained with 
primary anti-iNOS and anti-H3K9me3 antibodies 
overnight in dark. Then the coverslips were stained 
with secondary antibodies for 2 h at room 
temperature. Finally the cells were mounted in 
mounting solution with DAPI and the images were 
analyzed using BX61 Olympus fluorescence 
Microscope and Cytovision Software7.2. 
 
 Flow cytometry analysis 
For flow cytometry analysis, THP-1 (2X105) and 
RAW 264.7 (2X105) cells were seeded onto 24-well 
cell culture plates. Cells were infected with Msm 
pSMT3 and Msm esxL for 24 h. The cells were then 
harvested and blocked with 0.1% BSA for 15 min 
on ice. The cells were then centrifuged at 2500 
r.p.m. for 5 min followed by staining with primary 
FITC-labelled anti-human MHC-II and anti-mouse 
MHC-II antibodies for 30 min on ice and then with 
secondary antibodies. Untreated cells were taken as 
negative controls. Flow cytometry was performed 
by analyzing 10,000 gated cells using a FACS 
Canto II flow cytometer and FACS Diva software.  
 
Chromatin immunoprecipitation (ChIP) assay 
For ChIP assay, RAW 264.7 (1X107) cells were 
seeded onto 100 mm tissue culture disks. Cells were 
infected with Msm pSMT3 and Msm esxL. For ChIP 
assay with G9a inhibition, RAW 264.7 were 
infected with Msm esxL and then treated with G9a 
inhibitor, UNC0638. After 24 h of infection cells 
were washed twice with 1X PBS and then 
crosslinked with 11% formaldehyde solution for 15 
min followed by 2.5M glycine treatment for 
quenching formaldehyde solution. The cells were 
then washed with ice cold 1X PBS twice. The cells 
were then harvested by scrapping using ice cold 1X 
PBS and centrifuged at 2500 r.p.m. for 5 min at 4 
oC followed by washing with 1X PBS. The pellets 
were then resuspended with ice cold 1ml Farnham 
buffer and then centrifuged at 2000 r.p.m. for 5 min 
at 4 oC. The pellet was resuspended with 300 µl of 
RIPA buffer and then kept on ice for 10 min 
followed by sonication in Bioruptor at high setting 
for a total time of 40 min, 30 seconds ON, 30 
seconds OFF at 4oC. The chromatin length was then 
verified and proceeded for further steps. The 
sonicated mixture was centrifuged at 14000 r.p.m. 
for 15 min at 4oC. The supernatant was collected, 
quantified and adjusted the volume with RIPA 
buffer so that each reaction has 150 µg/ml of 
chromatin. The suspension was then incubated with 
previously prepared Protein-A sepharose beads for 
1h at 4oC in rotator. After centrifugation at 1500 
r.p.m. for 2 min at 4oC, the supernatant was taken 
and incubated overnight with 6µg of antibodies 
against H3K9me2/3 and mouse IgG per IP at 4oC 
for in rotator. Next day, the suspensions were again 
incubated with Protein-A sepharose beads at 4oC 
for 2 h in rotator and then centrifuged at 2000 r.p.m. 
for 1min. The pellets were then washed using LiCl 
wash buffer (7-8times) and TE buffer (once). The 
pellet was then dissolved in IP elution buffer for 30 
min at RT and then the supernatants were left at 
65oC overnight for reverse crosslinking. Next day 
the RNA and protein were digested with RNase and 
Proteinase K to obtain purified DNA. The DNA 
(150µg) isolated from 1X107 cells was further 
processed for qPCR using specific primers for 
CIITApI, CIITApIII, CIITApIV and GAPDH 
promoter. The qPCR data were then normalized to 
input DNA. Primers for GAPDH promoter and 
antibody against mouse IgG both were used as 
negative controls [Table 2]. 
 
Cytokine Profiling 
RAW 264.7 cells (2X105) were seeded onto 24 
wells tissue culture plate and infected with Msm 
pSMT3 and Msm esxL. After 2 h of infection 20 
mg/ml gentamycin containing DMEM media was 
added to kill the extracellular bacteria. After 1h the 
cells were then co-cultured with spleenocytes 
isolated from BALB/C mice. After 24 h the 
supernatant was harvested and cytokine levels were 
estimated using Bioplex kit assay (Bio-Rad). 
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Statistical analysis  
All experiments were performed at least three times 
(n=3). Statistical analyses were performed using the 
Mann-Whitney U-test (two-tailed, equal 
variances). Significance was referred*** for P< 
0.001 as ** for P < 0.01 and * for P < 0.05. 
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Figure legends 
 
Figure 1: Genetic organization, growth analysis, bacterial survival and Mtb ∆esxL mutant 
construction. (A) Schematic representation of esxL in the M. tuberculosis H37Rv genome. RAW264.7 (B) 
and THP-1 (C) were infected with Msm pSMT3 and recombinant Msm esxL strains. The cells were lysed, 
and intracellular survival was determined 1, 8, and 24 h post-infection by a cfu assay. (D) In-vitro growth 
curve of the Msm WT, Msm pSMT3 and recombinant Msm esxL was determined by growing bacteria in 
7H9 medium and measuring O.D. (A600 nm). (E) Extracellular expression of esxL transcript was measured 
by qRT-PCR after growing Msm esxL in-vitro for 4, 12 and 24 h. RNA was isolated at different time points. 
cDNA was synthesized and the expression of esxL was determined using qRT-PCR. Transcript levels are 
represented relative to mRNA levels of Msm esxL at 4 h which is assigned a value of 1. The expression 
values were normalized with sigA. (F) Intracellular expression of esxL transcript was measured by qRT-
PCR. RNA was isolated from Msm esxL infected macrophages at different time points. cDNA was 
synthesized and the expression of esxL was determined using qRT PCR. Transcript levels are represented 
relative to mRNA levels of Msm esxL at 4 h which is assigned a value of 1. The expression values were 
normalized with sigA. (G) Schematic representation of construction of Mtb ∆esxL mutant by homologous 
recombination. The location of primers used for the confirmation of deletion mutant generation is depicted. 
(H) Confirmation of Mtb ∆esxL mutant generation. F1 and R2 primers were designed beyond the flanks, 
whereas R1 and F2 primers anneal to sacB-hygr cassette. PCR using F1 and R1 is expected to give no 
product with the Mtb (lane 1) and ~1.3 kb with the Mtb ΔesxL (lane 2); F2-R2 primer sets were expected 
to give no product with Mtb and ~1.5 kb in Mtb ΔesxL mutant. Amplificaiton of udgB with gene specific 
primers was performed as a control. The experiments were performed in triplicate (n=3). Results are shown 
as mean + S.D. ***, p < 0.001; **, p < 0.01; *, p < 0.05.; ns, not significant. 
 
 
Figure 2: Determination of NO production and iNOS expression in Msm pSMT3, Msm esxL, Mtb 
H37Rv and Mtb ΔesxL infected cells. (A) RAW264.7 cells were infected with Msm pSMT3 and 
recombinant Msm esxL for 48 h. The production of NO was quantified using Griess reagent. (B) The level 
of iNOS expression at mRNA level was quantified by using Real time PCR. Transcript levels of iNOS in 
Msm pSMT3 and Msm esxL infected macrophages were determined by qRT-PCR 24 h post infection. 
GAPDH was taken as internal control. (C) and (D) iNOS expression was checked by Western blotting (C) 
and fluorescence microscopic (D) analysis using iNOS specific antibody in Msm pSMT3 and Msm esxL 
infected macrophages. (E) THP-1 cells were infected with Mtb and Mtb ΔesxL mutant for 24 h. The level 
of iNOS was checked by Western blotting. The experiments were performed in triplicate (n=3). Results are 
shown as mean + S.D. ***, p < 0.001; **, p < 0.01; *, p < 0.05. 
 
Figure 3: Expression of CIITA and MHC-II in Msm pSMT3, Msm esxL, Mtb H37Rv and Mtb ΔesxL 
infected macrophages.  (A) RAW264.7 cells were infected with Msm pSMT3 and recombinant Msm esxL 
for 24 h. The transcript level of CIITA was quantified by using qRT-PCR. Uninfected cells were used as 
control. (B) RAW264.7 cells were infected with Msm pSMT3 and recombinant Msm esxL for 48 h. Cell 
lysates were prepared at indicated time points. CIITA expression was checked by Western blotting. (C) 
The level of CIITA after Mtb infection was checked by Western blotting. Expression of CIITA protein was 
determined in Mtb H37Rv infected THP-1 cells by Western blotting using an antibody specific to CIITA 
after 24, 48 and 72 h of infection. The Western blot and densitometry analysis shown is representative of 
at least two biological replicates. (D) Western blot analysis to check expression CIITA in THP-1 cells 
infected with Mtb and Mtb ΔesxL after 48 h of infection. The expression level of MHC-II was checked at 
both transcriptional (E) and translational (F) levels in RAW 264.7 cells infected with Msm pSMT3 and 
recombinant Msm esxL strains for 24 h. (G) THP-1 and (H) RAW 264.7 cells were infected with Msm 
pSMT3 and recombinant Msm esxL strains for 24 h. Flowcytometric analysis of MHC-II expression was 
determined by using anti-MHCII antibody and analyzed through 10,000 gated cells. (I) Expression of 
MHCII protein was determined in Mtb H37Rv infected THP-1 cells by Western blotting using an antibody 
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specific to MHCII after 24, 48 and 72 h of infection. (J) The level of MHCII was checked in Mtb H37Rv 
and Mtb ΔesxL infected THP-1 cells by Western blotting after 24 and 48 h of infection. For qRT-PCR, 
GAPDH was taken as an internal control. The experiments were performed in triplicate (n=3). Results are 
shown as mean + S.D. (error bars); **, p < 0.01. 
 
Figure 4: Analysis of IL-2, IL-6, IL-10 and TNF-α cytokines in RAW 264.7 and spleenocyte co-cultured 
cells infected with Msm pSMT3 and recombinant Msm esxL strains. The level of IL-2 (A), IL-10 (B), TNF-
α (C) and IL-6 (D) cytokines was determined by using Bioplex cytokine analysis kit.  Infected RAW 264.7 
cells were co-cultured with spleenocytes isolated from BALB/C mice in presence and absence G9a inhibitor 
(UNC0638) and cell supernants were collected after 24 of infection. The experiments were performed in 
triplicate (n=3). Results are shown as mean + S.D. (error bars); **, p < 0.01; *, p < 0.05. 
  
 
Figure 5: Expression of H3K9me2/3 in macrophages. RAW264.7 cells were infected with Msm pSMT3 
and recombinant Msm esxL for 24 h. The expression of H3K9me2/3 was determined by Western blotting 
(A) and fluorescence microscopy (B). (C) Western blot analysis of H3K4me3 and total H3 was performed 
in Msm pSMT3 and recombinant Msm esxL infected macrophages after 24 h of infection. (D) Expression 
of H3K9me2/3 was determined in M. bovis-BCG infected RAW 264.7 cells in presence and absence of G9a 
inhibitor (UNC0638) after 24 h infection. (E) The level of H3K9me2/3 was determined in Mtb H37Rv 
infected THP-1 by Western blotting using an antibody specific to H3K9me2/3 after 24, 48 and 72 h of 
infection. (F) Differentiated THP-1 cells were infected with Mtb and Mtb ΔesxL for 48 h. The level of 
H3K9me2/3 was checked by Western blotting.  The level of G9a expression was checked in Msm pSMT3 
and recombinant Msm esxL infected RAW 264.7 cells (G) and Mtb and Mtb ΔesxL infected THP-1 cells 
(H) by qRT-PCR. (I) RAW264.7 cells were treated with UNC0638 (G9a inhibitor) followed by infection 
with Msm pSMT3 and recombinant Msm esxL. Expressions of CIITA and H3K9me2/3 were checked by 
Western blotting after 24 h of infection. ChIP assay was performed to check the H3K9me2/3 enrichment at 
CIITA promoter (pIV) after infecting RAW264.7 cells with Msm pSMT3 and recombinant Msm esxL (J) 
and after treatment with G9a inhibitor (K) for 24 h. Quantification of the data was done by qRT-PCR using 
specific ChIP primers. GAPDH was taken as an internal control for qRT-PCR. GAPDH promoter was taken 
as an additional negative control for ChIP qRT-PCR. The experiments were performed in triplicate (n=3). 
Results are shown as mean + S.D. (error bars); ***, p < 0.001; **, p < 0.01; *, p < 0.05; ns, not significant. 
 
Figure 6: Role of P38, ERK and iNOS in CIITA and H3K9me3 expression. RAW264.7 cells were 
infected with Msm pSMT3 and recombinant Msm esxL for 24 h. The expression of p-P38 (A) and p-ERK 
(B) was estimated by Western blotting. (C) THP-1 cells were infected with Mtb and Mtb ΔesxL for 24 h 
and the level of p-P38 was determined by Western blotting. The level of H3K9me2/3 and CIITA was 
checked by Western blotting. The expression of CIITA and H3K9me3 was checked in Msm pSMT3 and 
recombinant Msm esxL infected cells after treatment with SB203580 (P38 inhibitor) (D) and U0126 (ERK 
inhibitor) (E). (F) The expression of CIITA, H3K9me3 and iNOS was checked in Msm pSMT3 and 
recombinant Msm esxL infected cells after treatment with 1400W (iNOS inhibitor).  The experiments were 
performed in triplicate (n=3). 
 
Figure 7:  Schematic representation of role of Mtb esxL in induction of hyper-methylation of H3K9, which 
down regulates the expression of CIITA, the major co-activator of MHCII. This results in down-regulation 
of MHCII expression, and reduced production of IL2.  
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Table 1: Oligos used in this study 
 
Sl no. Primer Name Sequence (5’>>3’) 
1. esxL FP GTCCCTGCAGGATGACCATCAACTATC 
2. esxL RP GTCCAAGCTTTCAGGCCCAGCTGGAG 
3. iNOS FP TTC CAA GAG CCT TGC TGT TT 
4. iNOS RP GTA GGT AAG GGC GTT GGT CA 
5. CIITA FP ACGCTTTCTGGCTGGATTAGT 
6 . CIITA RP TCAACGCCAGTCTGACGAAGG 
7. MHCII FP TGGGCACCATCTTCATCATTC 
8. MHCII RP GGTCACCCAGCACACCACTT 
9. GAPDH FP GAGAGGCCCTATCCCAACTC 
10. GAPDH RP TTCACCTCCCCATACACACC 
11. esxL FP GTTGACCGCGAGTGACTTTT 
12. esxL RP GGTTTGCGCCATGTTGTT 
13. SigA FP CCAAGGGCTACAAGTTCTCG 
14. SigA RP TGGATCTCCAGCACCTTCTC 
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Table 2: Oligos used in ChIP assay 
 
Sl no. Primer Name Sequence (5’>>3’) 
1. CIITApI FP GCATAGCAGATGCAAAACCA 
2.  CIITApI RP GGGCAGATTATTACAGATTAGTTGC 
3. CIITApIII FP ACGTCCAGAGAAACTCAATGC 
4. CIITApIII RP AGAGCTGTTAGGGACATGGTG 
5. CIITApIV FP CTACTGGCTCAAATCTGTCGTC 
6. CIITApIV RP CAGGCAGATCTCACTTAGACCA 
7. GAPDHpromoter FP GGATAGAATGTAGCCCTGGACTT 
8.  GAPDHpromoter RP TGTGCATGTATCTTTATTGGCTCT 
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Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 by guest on M
arch 31, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
22 
 
Figure 2 
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